Compound ID | 164
Synonym(s): LCB01-0371
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the 23S ribosomal RNA |
| Description: | Synthetic compound containing cyclic amidrazone group which promotes excretion of compound; less toxic than linezolid due to its rapid clearance and reduced plasma accumulation |
| Institute where first reported: | LegoChem Biosciences (South Korea) |
| Year first mentioned: | 2010 |
| Highest development stage: | Phase 2 (NCT05225558; NCT06004037) |
| Development status: | Active |
| Reason dropped: | NCT05225558 Clinical Trial terminated due to issues with enrolling subjects. |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/44205191 |
| Guide to Pharmacology: | delpazolid |
| Citations: |
|